Annual Current Liabilities
$159.45 M
+$15.79 M+10.99%
December 31, 2022
Summary
- As of February 11, 2025, MRTX annual total current liabilities is $159.45 million, with the most recent change of +$15.79 million (+10.99%) on December 31, 2022.
- During the last 3 years, MRTX annual current liabilities has risen by +$110.54 million (+226.03%).
Performance
MRTX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Current Liabilities
$137.38 M
-$2.61 M-1.87%
September 30, 2023
Summary
- As of February 11, 2025, MRTX quarterly total current liabilities is $137.38 million, with the most recent change of -$2.61 million (-1.87%) on September 30, 2023.
- Over the past year, MRTX quarterly current liabilities has increased by +$10.39 million (+8.18%).
Performance
MRTX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
MRTX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +11.0% | +8.2% |
| 3 y3 years | +226.0% | +103.9% |
| 5 y5 years | +1068.6% | +526.1% |
MRTX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -9.9% | -13.8% | -13.3% |
| 5 y | 5-year | at high | -69.3% | -24.0% | -64.4% |
| alltime | all time | at high | -97.7% | -24.0% | -98.0% |
Mirati Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $137.38 M(-1.9%) |
| Jun 2023 | - | $139.99 M(+12.4%) |
| Mar 2023 | - | $124.60 M(-21.9%) |
| Dec 2022 | $159.45 M(+11.0%) | $159.45 M(+25.6%) |
| Sep 2022 | - | $126.99 M(+6.6%) |
| Jun 2022 | - | $119.15 M(-3.6%) |
| Mar 2022 | - | $123.57 M(-14.0%) |
| Dec 2021 | $143.66 M(+101.0%) | $143.66 M(+17.7%) |
| Sep 2021 | - | $122.08 M(-32.5%) |
| Jun 2021 | - | $180.87 M(+134.6%) |
| Mar 2021 | - | $77.11 M(+7.9%) |
| Dec 2020 | $71.47 M(+46.1%) | $71.47 M(+6.1%) |
| Sep 2020 | - | $67.37 M(+16.8%) |
| Jun 2020 | - | $57.70 M(+2.9%) |
| Mar 2020 | - | $56.05 M(+14.6%) |
| Dec 2019 | $48.91 M(+87.0%) | $48.91 M(+38.4%) |
| Sep 2019 | - | $35.34 M(+25.2%) |
| Jun 2019 | - | $28.21 M(+12.4%) |
| Mar 2019 | - | $25.10 M(-4.0%) |
| Dec 2018 | $26.15 M(+91.6%) | $26.15 M(+19.2%) |
| Sep 2018 | - | $21.94 M(+21.0%) |
| Jun 2018 | - | $18.13 M(+13.2%) |
| Mar 2018 | - | $16.01 M(+17.3%) |
| Dec 2017 | $13.64 M(-9.1%) | $13.64 M(+0.5%) |
| Sep 2017 | - | $13.58 M(+15.7%) |
| Jun 2017 | - | $11.74 M(+4.0%) |
| Mar 2017 | - | $11.28 M(-24.8%) |
| Dec 2016 | $15.00 M(+53.1%) | $15.00 M(+9.8%) |
| Sep 2016 | - | $13.66 M(-0.9%) |
| Jun 2016 | - | $13.79 M(+27.5%) |
| Mar 2016 | - | $10.82 M(+10.4%) |
| Dec 2015 | $9.80 M(+81.6%) | $9.80 M(+0.3%) |
| Sep 2015 | - | $9.77 M(+37.7%) |
| Jun 2015 | - | $7.10 M(+38.8%) |
| Mar 2015 | - | $5.11 M(-5.3%) |
| Dec 2014 | $5.40 M | $5.40 M(-3.1%) |
| Sep 2014 | - | $5.57 M(-87.6%) |
| Jun 2014 | - | $44.84 M(+5.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $42.72 M(+10.5%) |
| Dec 2013 | $38.65 M(+623.8%) | $38.65 M(-7.0%) |
| Sep 2013 | - | $41.56 M(+147.5%) |
| Jun 2013 | - | $16.79 M(+189.2%) |
| Mar 2013 | - | $5.81 M(+8.7%) |
| Dec 2012 | $5.34 M(+43.0%) | $5.34 M(+8.1%) |
| Sep 2012 | - | $4.94 M(+44.4%) |
| Jun 2012 | - | $3.42 M(+23.7%) |
| Mar 2012 | - | $2.77 M(-25.9%) |
| Dec 2011 | $3.73 M(-26.5%) | $3.73 M(+10.3%) |
| Sep 2011 | - | $3.38 M(-25.7%) |
| Jun 2011 | - | $4.56 M(-27.4%) |
| Mar 2011 | - | $6.27 M(+23.5%) |
| Dec 2010 | $5.08 M(-19.3%) | $5.08 M(-11.5%) |
| Sep 2010 | - | $5.74 M(+8.5%) |
| Jun 2010 | - | $5.29 M(+3.9%) |
| Mar 2010 | - | $5.09 M(-19.1%) |
| Dec 2009 | $6.29 M(-22.9%) | $6.29 M(+10.8%) |
| Sep 2009 | - | $5.68 M(-21.0%) |
| Jun 2009 | - | $7.19 M(-3.7%) |
| Mar 2009 | - | $7.47 M(-8.5%) |
| Dec 2008 | $8.16 M(-36.9%) | $8.16 M(-58.4%) |
| Sep 2008 | - | $19.60 M(+57.6%) |
| Jun 2008 | - | $12.43 M(+5.0%) |
| Mar 2008 | - | $11.84 M(-8.5%) |
| Dec 2007 | $12.94 M(+57.4%) | $12.94 M(+20.4%) |
| Sep 2007 | - | $10.74 M(+31.4%) |
| Jun 2007 | - | $8.17 M(+11.2%) |
| Mar 2007 | - | $7.35 M(-10.6%) |
| Dec 2006 | $8.22 M(+110.6%) | $8.22 M(+12.0%) |
| Sep 2006 | - | $7.34 M(+7.1%) |
| Jun 2006 | - | $6.85 M(+5.1%) |
| Mar 2006 | - | $6.52 M(+67.0%) |
| Dec 2005 | $3.90 M(-2.7%) | $3.90 M(+17.4%) |
| Sep 2005 | - | $3.32 M(+12.9%) |
| Jun 2005 | - | $2.94 M(-9.5%) |
| Mar 2005 | - | $3.25 M |
| Dec 2004 | $4.01 M(-18.7%) | - |
| Dec 2003 | $4.93 M | - |
FAQ
- What is Mirati Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Mirati Therapeutics?
- What is Mirati Therapeutics annual current liabilities year-on-year change?
- What is Mirati Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Mirati Therapeutics?
- What is Mirati Therapeutics quarterly current liabilities year-on-year change?
What is Mirati Therapeutics annual total current liabilities?
The current annual current liabilities of MRTX is $159.45 M
What is the all time high annual current liabilities for Mirati Therapeutics?
Mirati Therapeutics all-time high annual total current liabilities is $159.45 M
What is Mirati Therapeutics annual current liabilities year-on-year change?
Over the past year, MRTX annual total current liabilities has changed by +$15.79 M (+10.99%)
What is Mirati Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of MRTX is $137.38 M
What is the all time high quarterly current liabilities for Mirati Therapeutics?
Mirati Therapeutics all-time high quarterly total current liabilities is $180.87 M
What is Mirati Therapeutics quarterly current liabilities year-on-year change?
Over the past year, MRTX quarterly total current liabilities has changed by +$10.39 M (+8.18%)